Benjamin Sacristan

[European Society of Cardiology Journals @ESC_Journals]

Maximum-fixed energy shocks (360-360-360J) were more effective and equally safe when compared with low-escalating energy shocks (125-150-200J) for cardioverting atrial fibrillation https://t.co/RkYCNILvck

@escardio @TomLuscher #EHJ #ESCcongress #freeaccess

[Benjamin Sacristan @BenjaminSacris1]

#ESC2019 DIRECT - Circulating DPP3 is a myocardial depressant factor: DPP3 inhibition rapidly and sustainably improves haemodynamics.

Procizumab (anti-DPP3) rapidly improved shortening fraction in mice with acute HF (60.7 vs. 48.1%, p= 3.32 ×10^−7)
@CardioOnline @CCF_cardio

[cardio-online 🫀 @CardioOnline]

#ESCCongress : Recommandation Syndromes Coronaires Chroniques. Baisse de prévalence de la maladie coronarienne, perte de vitesse de l’épreuve d’effort, prévention de la survenue d’IDM par la revascularisation et baptême du feu pour le Rivaroxaban. N. Nezzouhairi @CCF_cardio

[Benjamin Sacristan @BenjaminSacris1]

@LaBroit @CCF_cardio @escardio @CardioOnline awesome!

[Broitman @LaBroit]

ESC 2019 DIRECT – DAPA-HF
Dapagliflozin reduced the risk of worsening heart failure events and cardiovascular death in patients with HFrEF (16.3 % vs 21.2 % with placebo, p < 0,00001), including patients without diabetes !
#ESCCongress @CCF_cardio @escardio @CardioOnline